THE global leader in  blood management solutions for our customers

2014 Press Releases

Webcast ImageWebcast
Haemonetics Investor Day (Live)
05/20/14 at 10:00 a.m. ET
Haemonetics Investor Day
Tuesday, May 20, 2014 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Haemonetics Corporation at Raymond James Financial Inc Institutional Investors Conference (Replay)
03/04/14 at 8:05 a.m. ET
Haemonetics Corporation at Raymond James Financial Inc Institutional Investors Conference
Tuesday, March 4, 2014 8:05 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Q4 2014 Haemonetics Corporation Earnings Conference Call (Live)
04/28/14 at 8:00 a.m. ET
Q4 2014 Haemonetics Corporation Earnings Conference Call
Monday, April 28, 2014 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
Apr. 01, 2014Haemonetics Sets Date for Fourth Quarter and Full Fiscal Year 2014 Earnings Release: April 28, 2014
BRAINTREE, Mass., April 1, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) will announce its earnings for the fourth quarter and full fiscal year 2014 and will provide guidance for fiscal year 2015 on April 28, 2014 in a pre-market press release.  The Company will hold a webcast to discuss and answer questions about the press release at 8:00 am (EDT) on April 28, 2014. Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=5122981 Webca... 
Printer Friendly Version
Mar. 24, 2014Haemonetics Provides Update on U.S. Whole Blood Supply Tender
BRAINTREE, Mass., March 24, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that it was not selected to supply The American Red Cross with certain whole blood collection components.  The Company was informed that a competitor was chosen to supply these products on an exclusive basis.      Haemonetics provided the following information regarding its whole blood collection kit business with The American Red Cross: Haemonetics currently supplies 1.8 million in-line ... 
Printer Friendly Version
Feb. 13, 2014Haemonetics to Present at the Raymond James 35th Annual Institutional Investors Conference
BRAINTREE, Mass., Feb. 13, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the Raymond James 35th Annual Institutional Investors Conference in Orlando, FL on Tuesday, March 4, 2014 at 8:05 am Eastern time.  The public may access Mr. Concannon's presentation live via webcast at http://wsw.com/webcast/rj89/HAE The webcast will be archived and available for approximately 90 days.  Haemonetics (NYSE: HAE) is... 
Printer Friendly Version
Feb. 05, 2014Haemonetics Sets Date for Investor/Analyst Meeting - May 20, 2014
BRAINTREE, Mass., Feb. 5, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Tuesday, May 20th from 10:00 am to 2:00 pm at The State Room, 60 State Street in Boston, Massachusetts. (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The agenda for the meeting includes updates on the following: Whole Blood Strategy / U.S. Tenders / International Expansion Plans Hospital Based Blood Manageme... 
Printer Friendly Version
Jan. 27, 2014Haemonetics Reports 3rd Quarter Fiscal 2014 Revenue of $242 Million and $0.61 Adjusted EPS; Extends Multi-Year Agreements With Key Plasma Customers
BRAINTREE, Mass., Jan. 27, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported third quarter fiscal 2014 net revenue of $242.1 million, down 2%. The Company's base revenue, exclusive of the recently-acquired whole blood business, increased 1% in the third quarter and increased 4% on a constant currency basis.  Excluding currency impact, net revenue was flat in the quarter.(1)  (Logo:  http://photos.prnewswire.com/prnh/20120206/NE47232LOGO) GAAP net income was $16.3 mi... 
Printer Friendly Version
Jan. 12, 2014Haemonetics Announces Signing of Supply Agreement with HemeXcel at J.P. Morgan Health Care Conference
BRAINTREE, Mass., Jan. 12, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that it has entered into a multi-year agreement to supply the HemeXcel Purchasing Alliance LLC with certain whole blood collection components on an exclusive basis during calendar years 2014-2016.  The announcement was made in conjunction with the 32nd Annual J.P. Morgan Health Care Conference in San Francisco.    (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) "We are very p... 
Printer Friendly Version
Jan. 03, 2014Haemonetics Business Update at J.P. Morgan Health Care Conference Will Include Status of U.S. Whole Blood Tenders
BRAINTREE, Mass., Jan. 3, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that it will provide a general business update, including an update with respect to ongoing U.S. whole blood tenders, in conjunction with the 32nd Annual J.P. Morgan Health Care Conference in San Francisco.  Brian Concannon, President and CEO of Haemonetics, will comment on these tenders as part of a live webcast presentation at 10:00AM Pacific / 1:00PM Eastern time on Wednesday, January 15.  As pr... 
Printer Friendly Version
Jan. 02, 2014Haemonetics to Present at the 32nd Annual J.P. Morgan Health Care Conference
BRAINTREE, Mass., Jan. 2, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the 32nd Annual J.P. Morgan Health Care Conference in San Francisco on Wednesday, January 15, 2014 at 10:00 am Pacific time / 1:00 pm Eastern time.  (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )   The public may access Mr. Concannon's presentation live via webcast at http://jpmorgan.metameetings.com/confbook/healthcar... 
Printer Friendly Version